Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit



Status:Completed
Conditions:Constipation
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:December 2009
End Date:December 2010
Contact:Bradford A Whitmer, D.O.
Email:whitmer5@msu.edu
Phone:2482891272

Use our guide to learn which trials are right for you!

Methylnaltrexone for the Reversal of Opiate-Induced Constipation in the Intensive Care Unit

The purpose of this study is to determine if there will be a significantly higher incidence
of a bowel movement with methylnaltrexone vs. placebo within 4 hours +- 45 minutes with
decreased need for rescue medications in the intensive care unit in patients with
opioid-induced constipation. Patients will also be managed with an aggressive bowel
management protocol.


Inclusion Criteria:

- 18 years of age or older in the ICU

- Opioids for analgesia for at least 24 hours.

- Opioid-induced constipation with no bowel movement within the last 72 hours.

- Women of childbearing potential had negative pregnancy tests.

Exclusion Criteria:

- Contraindication to use of the GI tract

- Diarrhea on admission

- Bowel surgery within 8 weeks of admission

- Ileostomy or colostomy

- Not expected to live or stay more than 3 days in the intensive care unit

- Constipation that was not primarily caused by opioids (as determined by the
investigator)

- No opioid use in the last 24 hours,

- Mechanical gastrointestinal obstruction

- An indwelling peritoneal catheter

- Clinically active diverticular disease

- Fecal impaction

- Acute surgical abdomen

- History of Crohn's disease or ulcerative colitis

- On Palliative care

- Less than 18 years old

- Bowel movement in last 72 hours.
We found this trial at
1
site
Southfield, Michigan 48075
?
mi
from
Southfield, MI
Click here to add this to my saved trials